These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8379811)

  • 1. Type selective inhibition of microbial fatty acid synthases by thiolactomycin.
    Arimura N; Kaneda T
    Arch Microbiol; 1993; 160(2):158-61. PubMed ID: 8379811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of thiolactomycin on the individual enzymes of the fatty acid synthase system in Escherichia coli.
    Nishida I; Kawaguchi A; Yamada M
    J Biochem; 1986 May; 99(5):1447-54. PubMed ID: 3519604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of the antibiotic thiolactomycin inhibition of fatty acid synthesis of Escherichia coli.
    Hayashi T; Yamamoto O; Sasaki H; Kawaguchi A; Okazaki H
    Biochem Biophys Res Commun; 1983 Sep; 115(3):1108-13. PubMed ID: 6354189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of fatty acid synthesis by the antibiotic thiolactomycin.
    Hayashi T; Yamamoto O; Sasaki H; Okazaki H; Kawaguchi A
    J Antibiot (Tokyo); 1984 Nov; 37(11):1456-61. PubMed ID: 6511668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overproduction of beta-ketoacyl-acyl carrier protein synthase I imparts thiolactomycin resistance to Escherichia coli K-12.
    Tsay JT; Rock CO; Jackowski S
    J Bacteriol; 1992 Jan; 174(2):508-13. PubMed ID: 1729241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo and in vitro effects of thiolactomycin on fatty acid biosynthesis in Streptomyces collinus.
    Wallace KK; Lobo S; Han L; McArthur HA; Reynolds KA
    J Bacteriol; 1997 Jun; 179(12):3884-91. PubMed ID: 9190803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2003 Nov; 13(21):3685-8. PubMed ID: 14552758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimycobacterial action of thiolactomycin: an inhibitor of fatty acid and mycolic acid synthesis.
    Slayden RA; Lee RE; Armour JW; Cooper AM; Orme IM; Brennan PJ; Besra GS
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2813-9. PubMed ID: 9124847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological activity of enantiomeric pairs of 5-(Alk-2-enyl)thiolactomycin and 5-[(E)-Cycloalk-2-enylidenemethyl]thiolactomycin congeners.
    Ohata K; Terashima S
    Chem Pharm Bull (Tokyo); 2009 Sep; 57(9):920-36. PubMed ID: 19721252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetylene-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme.
    Senior SJ; Illarionov PA; Gurcha SS; Campbell IB; Schaeffer ML; Minnikin DE; Besra GS
    Bioorg Med Chem Lett; 2004 Jan; 14(2):373-6. PubMed ID: 14698162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity.
    Douglas JD; Senior SJ; Morehouse C; Phetsukiri B; Campbell IB; Besra GS; Minnikin DE
    Microbiology (Reading); 2002 Oct; 148(Pt 10):3101-3109. PubMed ID: 12368443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the fungal fatty acid synthase type I multienzyme complex.
    Johansson P; Wiltschi B; Kumari P; Kessler B; Vonrhein C; Vonck J; Oesterhelt D; Grininger M
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12803-8. PubMed ID: 18725634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel inhibitors of the condensing enzymes of the type II fatty acid synthase of pea (Pisum sativum).
    Jones AL; Herbert D; Rutter AJ; Dancer JE; Harwood JL
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):205-9. PubMed ID: 10727420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiolactomycin resistance in Escherichia coli is associated with the multidrug resistance efflux pump encoded by emrAB.
    Furukawa H; Tsay JT; Jackowski S; Takamura Y; Rock CO
    J Bacteriol; 1993 Jun; 175(12):3723-9. PubMed ID: 8509326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fatty acid composition and primer specificity of de novo fatty acid synthetase in Bacillus globispores, Bacillus insolitus, and Bacillus psychrophilus.
    Kaneda T; Smith EJ; Naik DN
    Can J Microbiol; 1983 Dec; 29(12):1634-41. PubMed ID: 6673817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis of branched long-chain fatty acids by species of Bacillus: relative activity of three alpha-keto acid substrates and factors affecting chain length.
    Naik DN; Kaneda T
    Can J Microbiol; 1974 Dec; 20(12):1701-8. PubMed ID: 4155346
    [No Abstract]   [Full Text] [Related]  

  • 17. Biosynthesis of branched-chain fatty acid in bacilli: FabD (malonyl-CoA:ACP transacylase) is not essential for in vitro biosynthesis of branched-chain fatty acids.
    Oku H; Futamori N; Masuda K; Shimabukuro Y; Omine T; Iwasaki H
    Biosci Biotechnol Biochem; 2003 Oct; 67(10):2106-14. PubMed ID: 14586097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reductase steps of the type II fatty acid synthase as antimicrobial targets.
    Zhang YM; Lu YJ; Rock CO
    Lipids; 2004 Nov; 39(11):1055-60. PubMed ID: 15726819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of branched long-chain fatty acids from the related short-chain -keto acid substrates by a cell-free system of Bacillus subtilis.
    Kaneda T
    Can J Microbiol; 1973 Jan; 19(1):87-96. PubMed ID: 4405510
    [No Abstract]   [Full Text] [Related]  

  • 20. Analogues of thiolactomycin as potential anti-malarial and anti-trypanosomal agents.
    Jones SM; Urch JE; Brun R; Harwood JL; Berry C; Gilbert IH
    Bioorg Med Chem; 2004 Feb; 12(4):683-92. PubMed ID: 14759729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.